Please assess the completion status of the following clinical trial:

Trial Title: Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of major depressive disorder~* HRSD(17) score of at least 14~* Presence and complaint of insomnia for at least 1 month~* Fluent in English~* Use of an effective form of contraception throughout the study~Exclusion Criteria:~* Other psychiatric disorders (e.g., bipolar disorder, post traumatic stress disorder, obsessive compulsive disorder, eating disorder)~* Psychotic symptoms~* Serious, unstable, or terminal medical condition~* Axis II diagnosis of antisocial, schizotypal, or severe borderline personality disorder~* Substance abuse~* Not willing to end other psychiatric treatment~* Previous electroconvulsive therapy or vagus nerve stimulation treatment during the last year~* Sleep apnea, restless leg, or periodic limb movement disorder (to be ruled out after first sleep study)~* Other sleep disorders~* Currently pregnant or breastfeeding~* History of seizure disorder~* Disease or condition that produces altered metabolism or hemodynamic responses~* Liver or kidney dysfunction~* Current use of any over the counter medications or herbs for mood or sleep benefits (e.g., melatonin, valerian, kava, hop extract, St. John's Wort, SAMe)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- MED+CBTI (Type: EXPERIMENTAL): Escitalopram plus Cognitive Behavioral Therapy for Insomnia
- MED+CTRL (Type: ACTIVE_COMPARATOR): Escitalopram plus Pseudo-desensitization Therapy for Insomnia

Based on this trial design, predict the completion outcome and termination type (if applicable).